Living with Liver Cancer

Reading time: 1 min
Reduce salt intake

Diet. Eat a balanced, low-salt diet, as liver cancer tends to cause fluid retention in the abdomen. 

Two beer mugs crossed out indicating that alcohol is forbidden.

Alcohol. Alcohol is one of the most damaging substances for the liver and its continued consumption is associated with rapid progression of liver cancer and lower survival. 

Cigarette crossed out on a "no smoking" poster

Tobacco. It is important to quit smoking, as it is linked to a loss of appetite and affects breathing capacity. 

Drug crossed out

Medication. Given that most patients have an associated liver disease, the use of nonsteroidal anti-inflammatories is generally not recommended due to the high risk of kidney failure and developing fluid retention. Similarly, drugs with a hypnotic effect (sleeping pills, antidepressants, etc.) should be used with caution and always under medical supervision. 

Woman doing exercise

Physical activity. Maintain a moderate level of physical activity and, as far as possible, a regular routine. 

Medical consultation

Managing the side effects of systemic treatment. Systemic treatment (targeted therapies) is often associated with side effects, most of them mild, that must be monitored by the medical team. Patients need to be aware of these side effects in order to prevent them or identify them early on, so they may start to receive support treatment.  

Emotional support between two women

Emotional support. There are different patient and family support groups offering advice and support from people who have gone through a similar situation. Ask staff at your health centre about such organisations.  

Substantiated information by:

Alejandro Forner González
Jordi Bruix Tudo
María Reig Monzón
Neus Llarch Alfonso

Published: 13 May 2020
Updated: 13 May 2020

The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.

Subscribe

Receive the latest updates related to this content.

Thank you for subscribing!

If this is the first time you subscribe you will receive a confirmation email, check your inbox

An error occurred and we were unable to send your data, please try again later.